| RS1343140664 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1343140692 |
CD46
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly |
| RS1343145658 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1343148883 |
OTOGL
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 84B, Autosomal recessive nonsyndromic hearing loss 84B |
| RS1343161886 |
PMM2
|
Health Risk |
Pathogenic/Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1343170313 |
FANCC
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1343177940 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1343179190 |
MRE11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1343199316 |
COL11A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1343207038 |
MYO7A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS1343210471 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1343211837 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS1343212063 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1343231277 |
BAG3
|
Health Risk |
Pathogenic/Likely pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS1343240837 |
SIX5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1343243319 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1343246818 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1343260515 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1343295267 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, SMAD3-related disorder |
| RS1343296636 |
PEPD
|
Health Risk |
Likely pathogenic |
— |
| RS1343304057 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS1343309278 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1343328054 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1343336951 |
SORL1
|
Health Risk |
Pathogenic |
— |
| RS1343339242 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS1343341933 |
BMP2
|
Health Risk |
Pathogenic |
— |
| RS1343346566 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS1343361571 |
POMT2
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 |
| RS1343381340 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1343390851 |
HPS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1343400778 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS1343417772 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1343418411 |
TRPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1343422507 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Inborn genetic diseases |
| RS1343435250 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1343441680 |
GALNT3
|
Health Risk |
Pathogenic |
— |
| RS1343463467 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1343494916 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1343506367 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1343536158 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1343555503 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS1343563508 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome 1 |
| RS1343579561 |
GREB1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cortical hyperechogenicity, Renal hypodysplasia/aplasia 3 |
| RS1343581366 |
CUBN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome type 1 |
| RS1343583459 |
TSHR
|
Health Risk |
Likely pathogenic |
— |
| RS1343614760 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1343618467 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1343626760 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1343630556 |
EXT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Exostoses, multiple |
| RS1343632105 |
ABCC6
|
Health Risk |
Likely pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS1343634751 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1343645070 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1343647718 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1343660563 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1343667900 |
ABCB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 3, ABCB4-related disorder |
| RS1343672462 |
FIG4
|
Health Risk |
Likely pathogenic |
— |
| RS1343679884 |
PNKP
|
Health Risk |
Likely pathogenic |
— |
| RS1343680080 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 8, Inborn genetic diseases |
| RS1343702415 |
SBF2
|
Health Risk |
Likely pathogenic |
— |
| RS1343729760 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS1343744787 |
CDHR1
|
Health Risk |
Pathogenic |
— |
| RS1343749498 |
TMEM126A
|
Health Risk |
Pathogenic |
— |
| RS1343775223 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1343780391 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome type 2A |
| RS1343783336 |
DHCR7
|
Health Risk |
Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS1343784849 |
HSD3B7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1343793848 |
PRDM5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1343799019 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1343828094 |
PNPLA2
|
Health Risk |
Pathogenic |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS1343829959 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1343840421 |
CUL3
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder without autism with seizures, Neurodevelopmental disorder without autism with seizures |
| RS1343867350 |
IMPDH1
|
Health Risk |
Pathogenic |
— |
| RS1343869103 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1343871627 |
ATP6V1B1
|
Health Risk |
Likely pathogenic |
— |
| RS1343881428 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Isolated focal cortical dysplasia type II |
| RS1343900269 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1343928865 |
CERKL
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 26, Inborn genetic diseases |
| RS1343931250 |
SLC24A5
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1343936087 |
CYP27A1
|
Health Risk |
Pathogenic |
— |
| RS1343936481 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1343944955 |
CTSC
|
Health Risk |
Pathogenic |
Periodontitis, aggressive 1 |
| RS1343990349 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, FLNB-Related Spectrum Disorders |
| RS1344008575 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS1344017069 |
DDC
|
Health Risk |
Pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS1344019160 |
STRC
|
Health Risk |
Pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS1344047706 |
OCA2
|
Health Risk |
Likely pathogenic |
SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES |
| RS1344063890 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS1344095646 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1344099907 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy, Nemaline myopathy 2 |
| RS1344100742 |
G6PC1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1344104003 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1344107562 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1344117870 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Hematuria |
| RS1344124533 |
EVC
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS1344126455 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Cardiovascular phenotype |
| RS1344137236 |
CERKL
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 26, Retinal dystrophy |
| RS1344172059 |
ABCC8
|
Health Risk |
Likely pathogenic |
12 conditions, 12 conditions |
| RS1344194115 |
YARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate C, Charcot-Marie-Tooth disease dominant intermediate C |
| RS1344198103 |
CYBA
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1344204097 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |